Telix Pharmaceuticals Ltd Detailed Program Update January 2019

MELBOURNE (Australia) 9th Jan 2019 – Telix Pharmaceuticals Limited provides detailed Program Update January 2019

Telix Pharmaceuticals Limited is pleased to provide a detailed Program Update January 2019.

Once a year we like to put out an update on all of our progress and share our vision for cancer care. If you’d like to understand how molecular imaging and targeted radiation may one day become a standard part of clinical care, please take a look!

Happy New Year,

Team Telix

To read our program update click here.